Cann Group Ltd. ( (AU:CAN) ) has issued an announcement.
Cann Group Limited has entered into supply agreements with eleven Chemist Warehouse pharmacy outlets in Queensland. This collaboration will see Cann supplying its Botanitech range of medicinal cannabis products, enhancing its market presence and potentially boosting its growth in the medicinal cannabis sector.
More about Cann Group Ltd.
Cann Group Limited is a company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. With research facilities and corporate headquarters in Melbourne, the company operates a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group offers a range of dried flower and oil products, active pharmaceutical ingredients, and extracts to customers both in Australia and globally. Additionally, the company owns Satipharm and its patent-protected capsule technology.
YTD Price Performance: 70.0%
Average Trading Volume: 1,400
Technical Sentiment Signal: Buy
Current Market Cap: $8.7M
Find detailed analytics on CAN stock on TipRanks’ Stock Analysis page.